Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome

References

• Burghen G A, Givens J R, Kitabchi A E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovary syndrome. J Clin Endocrinol Metab 1980; 50: 113–116
   PubMed Web of Science ®Google Scholar
• Chang R J, Nakamura R M, Judd H L, Kaplan S A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 356–359
   PubMed Web of Science ®Google Scholar
• Morales A J, Laughlin G A, Butzow T, Maheshwari H, Baumann G, Yen S SC. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and features. J Clin Endocrinol Metab 1996; 81: 2854–2864
   PubMed Web of Science ®Google Scholar
• Yildiz B O, Gedik O. Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia. Eur J Obstet Gynecol Reprod Biol 2001; 100: 62–66
   PubMed Web of Science ®Google Scholar
• Ardawi M SM, Rouzi A A. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005; 83: 1708–1716
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006; 86(Suppl 1)S13–S14
   PubMed Web of Science ®Google Scholar
• Essah P A, Nestler J E. Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril 2006; 86(Suppl 1)S18–S19
   Google Scholar
• Talbott E O, Zborowski J V, Rager J R, Boudreaux M Y, Edmundowicz D A, Guzick D S. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 5454–5461
   PubMed Web of Science ®Google Scholar
• Ciaraldi T P, El-Roeiy A, Madar Z, Reichart D, Olefsky J M, Yen S SC. Cellular mechanisms of insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 1992; 75: 577–583
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implication for pathogenesis. Endocr Rev 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Dunaif A, Xia J, Book C, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995; 96: 801–810
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S, Peraldi P, Budavari A, Ellis R, White M F, Spiegelman B M. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 1996; 271: 665–668
   PubMed Web of Science ®Google Scholar
• DeUgarte C M, Bartolucci A A, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005; 83: 1454–1460
   PubMed Web of Science ®Google Scholar
• Karter A J, Myer-Davis E J, Selby J V, D'Agostino Jr RB, Haffer S M, Sholinsky P, Bergman R, Saad M F, Hamman R F. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 1996; 45: 1547–1555
   PubMed Web of Science ®Google Scholar
• Fink R I, Kolterman O G, Griffin J, Olefsky J M. Mechanism of insulin resistance in aging. J Clin Invest 1983; 71: 1523–1535
   PubMed Web of Science ®Google Scholar
• Rowe J W, Minaker K L, Pallotta J A, Flier J S. Characterization of the insulin resistance of aging. J Clin Invest 1983; 71: 1581–1587
   PubMed Web of Science ®Google Scholar
• Haffner S M, D'Agostino R, Saad M F, Rewers M, Mykkanen L, Selby J, Howard G, Savage P J, Wagenknecht L E. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742–748
   PubMed Web of Science ®Google Scholar
• Bahceci M, Tuzcu A, Bahceci S, Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?. J Endocrinol Invest 2003; 26: 655–659
   PubMed Web of Science ®Google Scholar
• Ducluzeau P H, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 3626–3631
   PubMed Web of Science ®Google Scholar
• Heald A H, Whytehead S, Anderson S, Cruckshank K, Riste L, Laing I, Rudenski A, Buckler H. Screening for insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2005; 20: 84–91
   PubMed Web of Science ®Google Scholar
• Vankova M, Vrbikova J, Hill M, Cinek O, Bendlova B. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann NY Acad Sci 2002; 967: 558–565
   PubMed Web of Science ®Google Scholar
• Ciampelli M, Fulghesu A M, Cucinelli F, Pavone V, Caruso A, Mancuso S, Lanzone A. Heterogeneity in β-cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 1997; 12: 1897–1901
   PubMed Web of Science ®Google Scholar
• Ciampelli M, Fulghesu A M, Murgia F, Guido M, Cucinelli F, Apa R, Caruso A, Lanzone A. Acute insulin response to intravenous glucagon in polycystic ovary syndrome. Hum Reprod 1998; 13: 847–851
   PubMedGoogle Scholar
• Ke W X, Shan G Q, Hua S Y. Different responses of insulin, C-peptide, and testosterone to an oral glucose tolerance test in two groups of women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 1996; 75: 166–169
   PubMed Web of Science ®Google Scholar
• Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 1994; 78: 1052–1058
   PubMed Web of Science ®Google Scholar
• Tropeano G, Luciano A, Liberale I, Barini A, Vuolo I P, Martino G, Menini E, Dell'Acqua S. Insulin, C-peptide, androgen, and β-endorphin response to oral glucose in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1994; 78: 305–309
   PubMedGoogle Scholar
• Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 2586–2593
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Vankova M, Bendlova B, Vondra K, Hill M, Starka L. Insulin sensitivity and β-cell function in women with polycystic ovary syndrome. Diabetes Care 2002; 25: 1217–1222
   PubMed Web of Science ®Google Scholar
• O'Meara N M, Blackman J D, Ehrmann D A, Barnes R B, Jaspan J B, Rosenfield R L, Polonsky K S. Defects of β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1241–1247
   PubMed Web of Science ®Google Scholar
• Goodarzi M, Erickson S, Port S C, Jennrich R I, Korenman S G. β-Cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 310–315
   PubMed Web of Science ®Google Scholar
• Arslanian S A, Lewy V D, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 66–71
   PubMed Web of Science ®Google Scholar
• Dunaif A, Finegood D T. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 942–947
   PubMed Web of Science ®Google Scholar
• Ehrmann D A, Sturis J, Byrne M M, Karrison T, Rosenfield R L, Polonsky K S. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995; 96: 520–527
   PubMed Web of Science ®Google Scholar
• Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 2007; 192: 585–594
   PubMed Web of Science ®Google Scholar
• Genazzani A D, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 2004; 81: 114–119
   PubMed Web of Science ®Google Scholar
• Genazzani A D, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani A R. Metformin administration modulates neurosteroids secretion in non-obese amenorrheic patients with polycystic ovary syndrome. Gynecol Endocrinol 2006; 22: 36–43
   PubMed Web of Science ®Google Scholar
• Genazzani A D, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni V M. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol 2007; 23: 146–152
   PubMed Web of Science ®Google Scholar